Trials Beyond The Clinic?
Regeneron Stock Up 19.7% After Positive VEGF Trap-Eye Report
By Tom Wall
Tuesday, November 23, 2010
The talk from Regeneron Pharmaceuticals Inc. is of trials clinical and, perhaps, legal. (BioWorld Today)
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.